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ABSTRACT
Recent advances in epigenetic research have enabled the development of epigenetic clocks, which have greatly enhanced our ability to
investigate molecular processes that contribute to aging and age-related disease. These biomarkers offer the potential to measure the effect of
environmental exposures linked to dynamic changes in DNA methylation, including nutrients, as factors in age-related disease. They also offer a
compelling insight into how imbalances in the supply of nutrients, particularly B-vitamins, or polymorphisms in regulatory enzymes involved in
1-carbon metabolism, the key pathway that supplies methyl groups for epigenetic reactions, may influence epigenetic age and interindividual
disease susceptibility. Evidence from recent studies is critically reviewed, focusing on the significant contribution of the epigenetic clock to
nutritional epigenomics and its impact on health outcomes and age-related disease. Further longitudinal studies and randomized nutritional
interventions are required to advance the field. Curr Dev Nutr 2020;4:nzaa097.
Keywords: aging, B-vitamins, diet, DNA methylation, epigenetic age, epigenetic age acceleration, epigenetic clock, one-carbon metabolism
Copyright C© The Author(s) on behalf of the American Society for Nutrition 2020. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Manuscript received March 10, 2020. Initial review completed April 27, 2020. Revision accepted May 21, 2020. Published online June 6, 2020. doi: https://doi.org/10.1093/cdn/nzaa097
The research described in this review was supported in part by Northern Ireland Chest Heart & Stroke Association (NICHS206_07; DJL-M and MW), DSMNutritional Products (MW, HN, JJS, and
CH), Economic and Social Research Council/Biotechnology and Biological Sciences Research Council (ES/N000323/1; CPW and DJL-M), and Vice Chancellor’s Research Scholarship, Ulster
University (SDA). SDA was the recipient of travel grants from the Nutrition Society, Biochemical Society, and Genetics Society.
None of the entities providing support were involved in the design, implementation, analysis, interpretation of the data, or in the production of the final review manuscript.
Author disclosures: MW, HN, and JJS hold an international patent on the use of riboflavin in the treatment of blood pressure. All other authors report no conflicts of interest.
Address correspondence to DJL-M (e-mail: dj.lees@ulster.ac.uk).
Abbreviations used: CGI, CpG island; CVD, cardiovascular disease; DMR, differentially methylated region; DNMT, DNA methyltransferase; EEAA, extrinsic epigenetic age; EWAS, epigenome-wide
association studies; IEAA, intrinsic epigenetic age; MTHFR, methylenetetrahydrofolate reductase; MZ, monozygotic; RCT, randomized controlled trial; SAM, S-adenosylmethionine; TET, ten-eleven
translocation methylcytosine dioxygenase enzyme; WGBS, whole-genome bisulfite sequencing; 5mC, 5-methyl cytosine.
Introduction
Epigenetic regulation has been identified as a key factor in aging (1)
and is linked with diet, metabolism, and disease (2, 3). During the last
decade, novel epigenetic clock models to identify DNA methylation sig-
natures that accurately predict chronological age, disease, and mortal-
ity, have also provided a measure of epigenetic or biological age. Epi-
genetic clocks offer immense potential to improve our understanding
of the significant current global challenge of the disparity between the
lengthening of average lifespan (4), which has not been matched by
similar improvements in healthspan, with relatively static rates of age-
related disease (5). During the last decade, the application of epigenetic
clock models to data generated by epigenome-wide association studies
(EWAS) focused on dietary intakes and nutritional intervention is help-
ing to uncover dietary determinants of healthy aging.
Maintaining optimal nutritional status will have an important con-
tribution to improving health outcomes with respect to age-related
disease and healthspan. Several dietary factors are emerging as key
modifiers of biological age and epigenetic clock models are help-
ing to unravel the complex interplay of diet and age-related dis-
ease. Folate and related B-vitamins, essential cofactors in 1-carbon
metabolism, the main metabolic pathway for generating methyl groups
for DNA methylation (6), are emerging as factors that can modify epi-
genetic age. Perturbations to DNA methylation owing to imbalances
in the supply of B-vitamins, or to polymorphisms or interactions be-
tween the various regulating enzymes, could lead to aberrant DNA
methylation and subsequently influence epigenetic age and disease
susceptibility (7).
Suboptimal B-vitamin status is associated with accelerated ag-
ing of the brain, declining cognitive function, and cardiovascu-
lar disease (CVD), indicating that B-vitamins may play protec-
tive roles in age-related disease (8–10). High prevalence of low
dietary intakes for B-vitamins (i.e., below the estimated average
requirement; EAR), including folate (29–35%), vitamin B-6 (24–
31%), and riboflavin (31–41%) have been reported in older adults
(11). More recent estimates from older adults (n = 5290; ≥50 y)
from the Irish Longitudinal Study on Ageing (TILDA) (Wave 1)
and (n = 5186) from the Trinity Ulster Department of Agricul-
ture (TUDA) study reported the prevalence of deficient or low vi-
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FIGURE 1 Brief summary of 1-carbon metabolism and DNA methylation. BER, base excision repair enzymes; BHMT,
betaine-homocysteine S-methyltransferase; DHF, dihydrofolate; DMG, dimethylglycine; DNMT, DNA methyltransferase; MTHFR,
methylenetetrahydrofolate reductase; MTR, methionine synthase; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine; SHMT,
serine hydroxymethyltransferase; TDG, thymine DNA glycosylase; TET, ten-eleven translocation methylcytosine dioxygenase enzymes;
THF, tetrahydrofolate.
whereas the prevalence of deficient/low folate status was ≤15%
(12, 13).
Application of epigenetic clock models to epigenomic data from di-
etary interventions or longitudinal studies of dietary intake offer im-
mense potential for elucidating how nutrition can modulate age-related
disease processes and improve health outcomes. As the volume of stud-
ies investigating the effect of nutrients, in particular B-vitamins, on
DNA methylation in health and disease begin to increase, understand-
ing the essential role of these nutrients in modulating DNA methylation
age and age acceleration are critical.
The aim of this literature review was to address this gap by provid-
ing a critical overview of recent studies using the epigenetic clock to
predict biological age and age-related disease and the application of nu-
trition in modifying these parameters. Further longitudinal studies and
randomized nutritional interventions are required. Additionally, chal-
lenges with methodology are highlighted and opportunities presented
for researchers to consider for advancement of the field of nutritional
epigenomics and age-related disease.
Literature search strategy
The literature search for this review was conducted by searching the
Medline (via OvidSP) database and PubMed for articles published in
English only and limited to human studies. Both medical subject head-
ings and keywords were used in the search to identify articles with rele-
vant information on aging, DNA methylation clock, diet, and vitamins.
This was subsequently followed by forward citation searching or “snow-
balling” whereby relevant references were identified from key articles,
followed up, and repeating the process with each article used to obtain
more literature.
Medical subject headlines included: exp DNA Methylation/, exp Di-
etary Supplements/, exp Micronutrients/, Vitamins/, Vitamin B Com-
plex/, Food, Fortified/, genome-wide methylation.mp. or Methylation/,
Aging/or Biological Clocks/or Epigenetic clock.mp. or DNA Methyla-
tion/. The keywords used were: (diet or nutrient or cobalamin or folate
or methionine or betaine or choline or riboflavin or “vitamin b2” or “vi-
tamin b12”) or (“methylation clock” or 450K or Methyl450 or Methyla-
tion450 or beadchip or “bead chip” or 800k or epic or EWAS or genome-
wide or genomewide or epigenome-wide or epigenomewide). Finally,
only those articles with emphasis on vitamins, diet, micronutrients, and
methylation clocks were selected, and the relevant data was extracted
for the review.
DNA Methylation and 1-Carbon Metabolism
DNA methylation
DNA methylation is widely regarded as the most stable epigenetic
mark involved in establishing patterns of gene expression and pheno-
type (14). It usually involves the covalent binding of methyl groups
to the 5’ position of a cytosine (5C) to form 5’-methylcytosine (5mC)
and occurs within CpG dinucleotide sequences (15). DNA methyla-
tion may also occur at non-CpG sites, such as CpA, CpT, and CpC;
however, the functions and mechanisms of such methylation and im-
plications for gene expression are currently not fully understood (16).
This review, therefore, focuses on DNA methylation at 5mC. Methy-
lation reactions are catalyzed by a family of DNA methyltransferases
(DNMTs) which transfer a methyl group from S-adenosylmethionine
(SAM) (Figure 1). Removal of DNA methylation can occur via passive
(failure to maintain methylation following replication) or active mech-
anisms. Active demethylation is carried out by the ten-eleven translo-
cation methylcytosine dioxygenase enzymes (TETs) recently reviewed
in (17) to produce 5mC derivatives, 5’-hydroxymethylcytosine (5hmC),
5’-formylcytosine (5fC), and 5’-carboxylcytosine (5caC). Additionally,
the 5caC is then removed through the action of the base excision repair
enzyme thymine DNA glycosylase (TDG) (18) (Figure 1).
DNA methylation has differing functions, depending on its location
within the genome. It is usually associated with transcriptional gene re-
pression at CpG-rich promoters; however, a mechanistic link between
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gene body methylation and active transcription is also suggested by en-
richment of 5mC within gene bodies of transcribed genes (19). CpG
sites dispersed throughout the genome are usually methylated (20, 21),
unlike CpGs lying within distinct, CG-rich CpG islands (CGIs), often
found in the promoters of housekeeping genes (22), which are mostly
unmethylated (20, 21). In the regions immediately neighboring CpG is-
lands, CpG shores (≤2 kb from CGI) and CpG shelves (2–4 kb from
CGI), display higher levels of methylation, with variations at these loca-
tions having a stronger impact on gene expression than the CpG island
and may account for tissue-specific expression and disease variability
(23, 24). Additionally, methylation occurring at other genomic regions
including transcription start sites (TSS) and intergenic regions has also
been shown to influence transcription and gene expression (25, 26).
DNA methylation modifications are dynamic, extensively repro-
grammed in early development (27, 28), and continue to a lesser, but
nonetheless important extent throughout the lifespan, owing to the in-
fluence of various environmental conditions, particularly diet, which
importantly contribute to both the aging process and disease suscep-
tibility (29).
Influence of nutrients on DNA methylation
One-carbon metabolism provides a direct link between nutrients,
mainly folate and related B-vitamins, and DNA methylation (Figure 1)
and therefore has become of interest to investigate in epigenetic stud-
ies. The interconnected biochemical pathways generate methyl groups
for the synthesis of purines and thymidine, and biological methylation
reactions including DNA, RNA, and histone methylation. Folate and
related B-vitamins: vitamin B-12, vitamin B-6, and the largely over-
looked vitamin B-2 (riboflavin), and other nutrients including me-
thionine, choline, and betaine provide substrates and cofactors to help
the efficient functioning of the system. Folate from the diet or in
the synthetic form, folic acid, is converted to 5-methyltetrahydrofolate
(5-mTHF) and dihydrofolate (DHF), respectively, and subsequently
to tetrahydrofolate (THF) (30). Tetrahydrofolate is then converted
to 5,10-methylenetetrahydrofolate and subsequently to 5-mTHF by
methylenetetrahydrofolate reductase (MTHFR) with vitamin B-2 (ri-
boflavin) as a cofactor. 5-mTHF is then demethylated as the 1-carbon
is donated for remethylation of homocysteine to methionine by me-
thionine synthase (MTR) with vitamin B-12 as a cofactor (31). 5,10-
methylenetetrahydrofolate dehydrogenase (MTHFD1), catalyzes the
conversion of tetrahydrofolate to 10-formyl, 5,10-methenyl, and 5,10-
methylene derivatives subsequently used as cofactors for de novo purine
and pyrimidine synthesis (30, 32). The choline-betaine pathway is a par-
allel pathway that involves the transfer of a methyl group from betaine to
homocysteine, a vitamin B-6 dependent reaction, to produce dimethyl-
glycine (DMG) and methionine.
Methionine regenerated from homocysteine serves as a precursor
for SAM and is then converted to S-adenosylhomocysteine (SAH) dur-
ing the methyl transfer (33). The cellular potential for DNA methylation
relies upon the relative amounts of the methyl donor SAM and its reac-
tion product SAH (34). The effects of dietary intake or supplementation
with B-vitamins has been shown in a limited number of studies to in-
crease SAM concentrations (35, 36). Supplementation with riboflavin
(1.6 mg/d for 16 wk) and folic acid (5 mg/d for 8 wk) increased mean
plasma SAM concentrations in adults with the MTHFR 677TT geno-
type (35, 36). It has been postulated that the higher the SAM:SAH ratio,
the greater the methylation potential of the cell, although conflicting
evidence suggests that DNA methylation may proceed without changes
in the ratio (37, 38). Further studies are required to clarify the effect of
dietary molecules on SAM concentrations and DNA methylation.
Perturbations in 1-carbon metabolism may occur through low in-
take of nutrients involved in 1-carbon metabolism (7), malabsorption
of nutrients via disease or cellular conditions, interactions in regulatory
enzymes in 1-carbon metabolism pathways as well as common poly-
morphisms within genes that code for enzymes important for the nor-
mal functioning of 1-carbon metabolism (2, 39). Apart from significant
disruption to 1-carbon metabolism, these perturbations may have func-
tional implications on downstream biological processes including DNA
methylation and synthesis.
Common polymorphisms in genes involved in 1-carbon
metabolism
Common polymorphisms in genes involved in 1-carbon metabolism
can influence enzyme activities, and subsequently metabolite and sub-
strate concentrations in the pathway. The MTHFR C677T polymor-
phism results in reduced MTHFR enzyme activity in individuals with
the 677TT genotype which encodes a thermolabile enzyme (40). Ele-
vated plasma homocysteine indicates perturbed 1-carbon metabolism
in 677TT individuals, and it is plausible that altered concentrations
of SAM and, therefore, availability of methyl donors for methylation
reactions may ensue. The well-established phenotype of elevated ho-
mocysteine is widely reported in different populations. A large-scale
population-based study (n = 10,601) found strong associations of
MTHFR c665C > T polymorphism with blood concentrations of to-
tal plasma homocysteine and serum folate (41). The 665TT genotype
was associated with a higher concentration of homocysteine and lower
concentration of folate than the 665CC genotype, with the CT geno-
type having intermediate concentrations. Riboflavin supplementation
in a randomized controlled trial (RCT) of adults reduced plasma homo-
cysteine specifically in 677TT individuals (42) indicating that riboflavin
may stabilize the thermolabile enzyme and restore MTHFR activity, and
thus is a very interesting nutrient for future epigenetic investigations. A
recent study by our group using evidence from RCTs showed that sup-
plementation with riboflavin resulted in decreased global and MTHFR
north shore methylation in adults with the MTHFR 677TT genotype
(43).
Polymorphisms can also act as strong cis-regulatory elements (cis-
meQTL; cis-methylation quantitative trait loci) to regulate the methy-
lation levels of their own gene promoter or trans-regulatory elements
(trans-meQTL) regulating methylation of other genes. For example, 57
CpGs were differentially methylated depending on the genotype of 6 1-
carbon metabolism genes (FTHFD, MTHFD1, MTHFR, MTR, MTRR,
and TYMS; P <0.5 × 10−5). The MTHFR rs1801133 single nucleotide
polymorphisms (SNPs) (responsible for the C677T polymorphism) was
shown to act as a trans-meQTL regulatory element in breast tissue
associated with lower methylation of 5 CpGs (CLEC17A, DLX6AS,
cg13811423, cg14118666, and cg181152144; average OR = 0.15; aver-
age 95% CI: 0.05–0.42) (44). The MTHFR promoter itself is also a target
for trans-meQTL regulatory elements such as the DNMT3B −149C > T
polymorphism. Increasing the number of T alleles at this position sig-
nificantly increased MTHFR methylation with the DNMT3B −149CC
genotype having significantly lower levels of MTHFR methylation than
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the CT genotype, which in turn had significantly lower levels of methy-
lation than subjects with the TT genotype (45).
Role of DNA methylation and diet in aging and disease
The aging process is complex and involves numerous changes at both
the molecular and cellular level, including epigenetic remodeling of the
DNA methylome (46, 47). DNA methylation patterns, established early
in development, progressively diverge throughout the life course, with
age-associated DNA methylation features identified by middle-age at a
large number of CpG sites continuing to undergo changes into old age
(48). Changes in DNA methylation associated with age have been ob-
served in many cross-sectional studies; however, longitudinal evidence
which is not confounded by interindividual differences is more limited.
In such studies, longitudinal analysis of a cohort of elderly twin pairs
identified 2284 CpG sites where DNA methylation levels changed over
a 10-y follow-up period (49). A 20-y study of 385 older Swedish twins
also identified 1316 longitudinal age-associated methylation sites that
were validated in 2 independent cohorts (50). Although it is now well
accepted that epigenetic alterations are hallmarks of aging, understand-
ing the causality between these epigenetic changes and the aging pro-
cess has not been fully elucidated and is still an active area of investi-
gation (51). Multiple studies have reported not only significant associa-
tions between aging and DNA methylation (52, 53) but also associations
between age-related diseases and epigenetic alterations. The processes
that drive the changes in the aging methylome, and subsequent impli-
cations for disease and mortality risk are currently not well understood;
however, several potential mechanisms have been proposed. These in-
clude effects on immunity and inflammation, whereas environmental
factors, such as diet, stress, physical activity, socioeconomic status, and
smoking (52, 54, 55, 56) could impact these mechanisms or act directly
to age the methylome. Aging-associated immune-system impairments
are mediated via changes in DNA methylation in nonagenarians. In a
cross-sectional analysis of 4173 postmenopausal females, age-related
changes in immune functioning and inflammation were also shown
to contribute to increased susceptibility to a wide range of diseases
(57, 58).
Dietary factors, particularly B-vitamins, may modulate DNA methy-
lation and thereby influence age-related disease. In studies investigating
B-vitamins and DNA methylation in disease, Fiorito and colleagues (59)
reported that DNA methylation of specific genes (TCN2, CBS, PON1,
AMT) involved in 1-carbon metabolism and homocysteine metabolic
pathways could mediate the CVD risk conferred by low dietary in-
take of B-vitamins. Furthermore, using highly robust and comprehen-
sive microarray methods, several large EWAS have shown that sup-
plementation with B-vitamins, predominantly folate and vitamin B-
12, or dietary intake of these nutrients modulate DNA methylation at
the genome-wide level in older adults (Table 1), highlighting key tar-
gets that could be further explored in age-related nutritional epige-
nomics studies (60, 61). Riboflavin has not been as widely studied as
other B-vitamins with only 1 EWAS reporting the effects of variabil-
ity in dietary intake on DNA methylation. Low dietary intake of ri-
boflavin was associated with higher methylation at 1 CpG (cg21230392;
P = 5×10-8) in a study involving participants from the Melbourne
Collaborative Cohort Study (MCCS) (62). Additionally, supplementa-
tion with flavanols and polyphenols may affect the activity of enzymes
including DNMTs and significantly impact methylation (63). For ex-
ample, (-)-epigallocatechin-3-gallate (EGCG), a key polyphenol in tea
inhibits DNMT activity resulting in demethylation and reactivation of
methylation-silenced genes in cancer cells. Further evidence from RCTs
of nutrients, such as riboflavin supplementation could elucidate how in-
dividual nutrients influence the epigenome and age-related disease.
Epigenetic Clocks
Epigenetic drift versus epigenetic clock
Studies of monozygotic (MZ) twins have shown that although twins
are epigenetically indistinguishable during the early years of life, older
MZ twins exhibited remarkable differences in their epigenome, indi-
cating that patterns of epigenetic modifications in MZ twin pairs di-
verge as they become older (64). Entropic decay of DNA methylation
during aging is observed with twin studies also revealing that repeat
sequences generally become more hypomethylated during aging (65,
66), with methylation increases noted at individual regulatory locus-
specific regions (67) (Figure 2). Tissue-dependent DNA methylation
variation may explain why particular organs and tissue are susceptible to
different diseases (68). Many methylation changes leading to interindi-
vidual divergence occur stochastically during aging and are known as
“epigenetic drift.” Specific CpG sites have been identified to undergo
reproducible methylation changes across individuals with age allow-
ing their utilization in epigenetic clock algorithms (69), which can be
used to accurately predict chronological age and estimate biological age
(Figure 2).
Epigenetic clocks and age acceleration
Chronological age as a predictor of disease risk and mortality is subop-
timal as individuals with the same chronological age may exhibit dif-
ferent susceptibility to age-related diseases owing to differences in un-
derlying biological aging processes (70). This has led to the advent of
several DNA methylation-based models of biological aging known as
epigenetic clocks (Table 2). Each clock is derived by a linear regression
algorithm that trains against the chronological age of sample donors and
selects a set of CpGs, determining the weighted contribution of each
CpG in the set to produce a DNA methylation age (DNAm Age) that
correlates accurately with chronological age. The first of these to have a
major impact was the Horvath clock (69), which analyses methylation
at 353 CpGs and was developed using a panel of 51 different noncancer-
ous tissues and cell lines, leading to it being known as a pan-tissue clock.
This feature has enabled accurate predictions of DNAm Age across het-
erogeneous tissues and cell types. Owing to the wide age range of indi-
viduals from which the samples were derived, the Horvath clock is also
known as a life course clock and is applicable to analysis of epigenetic
age in children and perinatal samples (71). The Hannum methylation
clock (56) was derived from the analysis of whole blood in 482 individ-
uals of either Caucasian or Hispanic ethnicity using 71 CpGs to provide
superior accuracy in age determination. A recent meta-analysis of over
41,607 participants indicated that each 5-y increase in DNA methyla-
tion age, estimated using either the Horvath or Hannum clocks, was
associated with an 8–15% increased risk of mortality (72).
When biological age (DNAm Age) exceeds chronological age, age
acceleration (AgeAccel) is said to be experienced and this measure is
perhaps of most interest to scientists and clinicians studying aging and
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FIGURE 2 DNA methylation patterns of monozygotic twins diverge during aging. Despite early similarities, stochastic changes occur in
the methylome of each twin, A and B during aging. Epigenetic drift results in age-related hypermethylation of CpG-rich sequences such as
CGI promoters, typically found in ubiquitously expressed housekeeping genes, which may be switched off as a result of aberrant
age-related methylation. In contrast, highly methylated, transcriptionally repressed CpG-poor promoters tend to become hypomethylated
during aging, leading to aberrant gene expression. Tandem satellite repeat sequences in the telomere are also heavily methylated which
may promote genome stability and inhibit recombination. Hypermethylated interspersed repeats such as LTRs, SINEs, and LINEs tend to
undergo generalized hypomethylation during aging. A selection of CpGs undergo programed reproducible methylation changes across
the population during aging and have been incorporated into epigenetic clock algorithms used to accurately predict epigenetic age. Each
lollipop represents an individual CpG, arrows indicate transcription start sites, X indicates transcriptional repression. CGI, CpG island;
LINE, long interspersed nuclear element; LTR, long terminal repeat; SINE, short interspersed nuclear element.
disease. AgeAccel is defined as the residual from regressing DNAm Age
on chronological age, where a positive value indicates that epigenetic
age is greater than expected. Horvath further characterized epigenetic
age acceleration as either intrinsic (IEAA) or extrinsic (EEAA) epige-
netic age acceleration. IEAA is a measure of age acceleration that is in-
dependent of age-related changes in the cellular composition of blood,
whereas EEAA captures the age-related functional decline of the im-
mune system and accounts for changes in blood cell composition such
as the decrease of naïve CD8+ T cells and the increase in memory or
exhausted CD8+ T cells (77).
To investigate biological age more extensively and discriminate mor-
bidity and mortality more accurately among individuals of the same
chronological age, recently developed clocks have been trained on age-
related and disease phenotypes in combination with chronological age.
Two of the most robust are the DNAm Phenotypic Age predictor
(DNAm PhenoAge) (78) and the DNAm-based biomarker of mortality
GrimAge (DNAm GrimAge) (79). The PhenoAge clock calculates phe-
notypic age in a 2-step process. Initially, 42 clinical blood biomarkers
that predict mortality in NHANES III were used to derive an estimate of
phenotypic age. Subsequently, refinement to select 9 of these biomark-
ers plus chronological age were used independently of DNA methyla-
tion to predict phenotypic age. In the final model, a phenotypic age was
calculated in the independent Invecchiare in Chianti (InCHIANTI) co-
hort and a DNA methylation proxy of phenotypic age (DNAm Phe-
noAge) and age acceleration (AgeAccelPheno) were derived based on
a set of 513 CpGs. The Horvath and Hannum clocks are not influenced
by smoking status; however, the DNAm PhenoAge clock includes this
disease-related factor associated with DNA methylation changes. The
PhenoAge clock was found to outperform the Horvath and Hannum
epigenetic age measures with respect to a variety of aging outcomes, in-
cluding all-cause mortality, cancers, healthspan, physical functioning,
and Alzheimer’s disease (78). The most recent of these biological clocks,
DNAm GrimAge, was trained using the Framingham Heart Study (78)
and tracks methylation of CpGs of blood-based protein biomarkers that
are known to be associated with health such as plasminogen activa-
tion inhibitor 1 (PAI-1) and growth differentiation factor 15 (GDF15),
as well as a more sensitive measure of CpGs associated with smoking
through an estimate of “pack years.” Incorporation of valuable infor-
mation from these loci has resulted in improvements in accuracy of age
acceleration (GrimAgeAccel), which has been shown to be 18% more
accurate than chronological age and 14% more accurate than previously
described clocks in predictions of time to disease (42). DNA methyla-
tion age is currently one of the most accurate measures of aging and life
expectancy in a range of traditional measures such as telomere length,
and proteomic, transcriptomic, and metabolomic biomarkers in accu-
rately estimating biological age (80).
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training Training set Key features
Horvath (69) 353 27K & 450K Multiple tissues
(n = 51)
Multiple studies, n = 7844,
mean age 43 y
Predicts methylation age across the
lifespan
Can be applied to children and
prenatal samples
Provides estimates of both intrinsic
and extrinsic epigenetic age
Estimations may be biased in older
adults
Hannum (56) 71 27K & 450K Blood 2 cohorts, n = 656
(n1 = 482; n2 = 174), age
range 19–101 y
Tailored to adult blood samples and
may lead to biased estimates in
children and in nonblood tissues
Age estimations may be
confounded by age-related
changes in blood composition
Provides a more accurate prediction
of life expectancy than Horvath
clock
PhenoAge (78) 513 27K, 450K, &
EPIC
Blood 2-step process: 1)
phenotypic age;
NHANES-III, n = 9926,
age >20 y
Biomarker relates to numerous
age-related diseases and disease
phenotypes
2) Epigenetic marker of
phenotypic age;
InCHIANTI, n = 456, age
range 21–100 y
Improved predictive power over




smoking-related changes in DNA
methylation
Captures organismal age and the
functional state of organs and
tissues
Estimations may be biased in
children and in nonblood tissues
GrimAge (79) 1030 450K & EPIC Blood Framingham Heart Study
(FHS), n = 2536 divided
into:
DNA methylation surrogates
developed for 7 plasma proteins
plus smoking pack years
1) training set n = 1731
from 622 pedigrees,
mean age 66 y
Currently best predictive epigenetic
biomarker for lifespan and time to
coronary heart disease (18% and
61%, respectively), more
predictive than chronological age
2) test set n = 625 from 266
pedigrees, mean age
67 y
Highlights healthy diet and
educational attainment as
predictors of biological age
Summary of the key features of the 4 current epigenetic clocks, including the number of CpGs included in algorithm, the platforms and tissues used in development
and the tissues used in training. 27K, Infinium 27K BeadChip array; 450K, HumanMethylation450K BeadChip array; EPIC, Infinium Methylation EPIC BeadChip (850K)
microarray; InCHIANTI, Invecchiare in Chianti, aging in the Chianti area.
The CpGs which are included in the clock algorithms are widely
distributed across the genome and do not appear to be clustered in
or near any particular genomic feature or any particular regulatory
region. The methylation clocks and associated challenges have been
extensively reviewed recently (81, 82). It is important to note that, al-
though these clocks are highly correlated with chronological age, they
were constructed using different algorithms which may influence their
prediction of disease and health outcomes; therefore, careful considera-
tion should be given to the most appropriate clock to utilize in any given
study.
Epigenetic clocks are not linear across the lifespan. Many of the cur-
rent epigenetic clock studies have been conducted in adults, and as a
result, many show impressive accuracy across most tissues during mid-
dle age (83). In later life, however, chronological age increases at a faster
rate than epigenetic age, particularly in the Horvath and Hannum clocks
(84). A nonlinear pattern is also observed in the clock during childhood
(71) and teenage years, due to a greater rate of DNA methylation change
in children than adults (85). The Horvath clock has been adjusted to
include a log linear transformation for data points from younger indi-
viduals and a new clock trained on pediatric buccal swabs has increased
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predictive power in samples from children (86). Furthermore, as none
of the clocks are well-suited to estimating gestational age, the recent
development of a placenta clock can be used to closely track fetal age
during development (87).
Epigenetic age, age acceleration, and health outcomes
Epigenetic age and age acceleration are strongly linked to all-cause mor-
tality, higher cancer and CVD mortality and are associated with impor-
tant inflammatory biomarkers including C-reactive protein, IL6, and
monocyte chemotactic protein (88, 89). Table 3 provides an overview
of age-related conditions, DNA methylation age, and age acceleration
measured by the 4 different clocks. Although the list is not comprehen-
sive, it is indicative of the broad range of age-related diseases associ-
ated with altered epigenetic age. Of particular note, CVD and related
measures such as blood pressure have emerged as age-related condi-
tions that are robustly correlated with methylation in a range of epi-
genetic clocks. Accelerated PhenoAge is associated with a higher risk
of coronary heart disease (β = 0.016–0.073; Meta P = 3.35 x 10-11 )
and both higher EEAA (r = 0.07, P = 4 x 10-6) and AgeAccelPheno
(r = 0.08, P = 1 x 10-6) are associated with elevated systolic blood
pressure (58, 78). GrimAgeAccel also gives the most accurate predic-
tions of time-to-coronary heart disease (HR = 1.07, P = 6.2 x 10-24)
and time-to-cancer (HR = 1.07, P = 1.3 x 10-12) and also demonstrates
a strong association with hypertension (OR = 1.04, P = 5.1 x 10-13)
(79).
Epigenetic age, age acceleration, and dietary factors
The influence of diet in the etiology of many age-related diseases is
well established and the advent of epigenetic clocks has brought a novel
approach to confirm diet as an important health factor (79). Epige-
netic age and age acceleration are linked to a variety of dietary fac-
tors such as fish, fruit, and vegetable intakes indicating that a healthy
diet and lifestyle could positively influence epigenetic age acceleration
(Table 4). For example, a previous study highlighted that ω-3 PUFA
supplementation and vegetable consumption appear to be associated
with lower GrimAgeAccel (41); however, as this association was made
from an observational study, further validation from prospective clin-
ical trials is required. Application of epigenetic clock models to epige-
nomic data from longitudinal studies or dietary interventions to mea-
sure biological age and age acceleration offer immense potential for elu-
cidating how dietary interventions can modulate the aging and disease
processes.
It also appears that sex and genotype may play a role in modu-
lating epigenetic age acceleration in response to dietary factors. The
epigenetic age acceleration lowering of ω-3 PUFAs also appears to be
more pronounced in males (GrimAgeAccel: r = −0.08, P = 0.012)
than in females (r = −0.05, P = 0.07). Furthermore, epigenome-wide
methylation results from the B-Vitamins for the PRevention Of Os-
teoporotic Fractures (B-PROOF) study, intervening with daily folic
acid and vitamin B-12 supplements in a robust 2-y RCT (73), were
inputted into the online DNA methylation age calculator to demon-
strate that AgeAccel is reduced in women with the MTHFR 677CC
but not the 677TT genotype (90). Careful consideration of sex and
genotype must therefore be undertaken in the design of epigenetic
studies.
In the first and currently the only study to indicate the possi-
bility of reversal of biological age, the Thymus Regeneration, Im-
munorestoration, and Insulin Mitigation (TRIIM) trial used a cock-
tail of drugs comprising recombinant human growth hormone (rhGH)
to prevent or reverse signs of immunosenescence in a 1-y pilot
trial of healthy men aged 51–65 y showing a regression of epige-
netic age of −2.5 y on average (70). Although the trial was small
(n = 9) and, crucially, did not include a control arm, suggestions
of biological age reversal were found in all 4 robust methylation
clocks available, and in each individual. This study was the first to
indicate that potential regression of multiple aspects and biomark-
ers of aging, including immune function, was possible in humans
(70).
Although itself not a dietary factor, it is interesting to note that
growth hormone, the supplement chosen in the aforementioned epi-
genetic age reversal trial, has been noted to perturb mRNA and protein
concentrations of DNMT1 (91) and it has been postulated that the age-
related dysfunction of growth hormone may play a role in the reduction
of DNMTs in aging (82). Further roles for age-related dietary factors
such as SAM and α-ketoglutarate (AKG) have been suggested to alter
activity of DNMTs and their counterpart TET enzymes during the aging
process. The observed age-associated decline in genome-wide methyla-
tion may be exacerbated by an observed age-related decline of the es-
sential DNMT substrate, SAM (92, 93), which could result in demethy-
lation of some clock CpGs. Indeed DNMT enzymes also decrease with
age in some tissues (91, 94). Furthermore, the hypermethylation of spe-
cific loci during aging may be attributable to the decline in AKG and
ensuing reductions in TET enzyme activity (82). AKG declines with age
(95), reducing its availability as a cofactor for TETs in active demethy-
lation reactions and ensuing hypermethylation of locus-specific regions
(96). In support of this theory, AKG has recently been demonstrated to
be a rate-limiting factor controlling DNA demethylation in aging mice
(95). This remains speculative, however, because no studies to date have
investigated the specific effects of these nutrients on enzyme activity or
epigenetic aging.
Despite their obvious strengths, DNA methylation-based clocks are
unlikely to replace existing clinical biomarkers and measurements such
as blood pressure, walking speed, and grip strength, which are cost-
effective and easy to perform. The cost of measuring DNA methyla-
tion age prevents the standard adoption of this method, at least until it
becomes more affordable. In fact, GrimAge is 61% more accurate than
chronological age and 46% more accurate than previously reported epi-
genetic clocks in predicting time to coronary heart disease. However,
despite this significant advancement, neither chronological nor Grim-
Age are entirely accurate estimators of coronary heart disease and fur-
ther work is required to determine their role as predictors of cardiovas-
cular and other disease outcomes.
Methodological Aspects of Studies Investigating DNA
Methylation and Diet
Despite the growing interest in the role of diet in influencing DNA
methylation and age-related disease, most previous studies in humans
were not designed with DNA methylation as the primary outcome, re-
sulting in limited data to provide concrete evidence linking the diet to
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DNA methylation. The methodological aspects of appropriate study de-
sign for the investigation of diet and DNA methylation will be discussed
further.
Study design and population
The study design utilized as well as dietary or biochemical data col-
lected are critical when investigating the link between nutrient intake
or status and DNA methylation. The majority of studies so far are
observational and have provided inconsistent evidence for the role of
dietary factors, especially B-vitamins, in modulating DNA methylation,
perhaps owing to inconsistencies in study design and choice of assay
(101). Although observational studies offer the advantage of providing
comprehensive data with large sample sizes and highlight associations
between nutrients and DNA methylation, they are unable to provide
clarity with respect to dietary causality. RCTs represent a robust study
design for establishing the effects of B-vitamins on DNA methylation;
however, studies of this nature are lacking. Although no study on its own
can prove causality, randomization in RCTs reduces bias and provides
a rigorous tool to examine cause-effect relations between an interven-
tion and an outcome (102). Additionally, apart from establishing the
biological roles of B-vitamins in modulating DNA methylation, there
is a need for RCTs to further incorporate dose-response design in or-
der to determine the optimum doses of B-vitamins required to mod-
ulate DNA methylation. Longitudinal studies that assess methylation
in individuals at several time points, and thereby reduce noise in the
methylation signal owing to interindividual variation, are particularly
useful in helping to elucidate the role of diet and methylation in dis-
ease. Furthermore, the majority of existing studies have employed FFQs
in estimating dietary intake, yielding only semiquantitative data, prone
to measurement errors that may not accurately reflect status, resulting
in misclassification which can compromise the ability to detect statisti-
cally significant associations (103). Importantly, biochemical biomarker
concentrations of status provide more reliable indicators than di-
etary intake to investigate the relation between B-vitamins and DNA
methylation.
Novel approaches for DNA methylation analyses in
nutrition studies
Methods to examine DNA methylation have evolved over the years and
have become more sophisticated. Although commonly used methods
including HPLC-UV, LC-MS/MS, methyl acceptance assay, and pyrose-
quencing are still useful in analyses of DNA methylation, novel tech-
nologies such as the Infinium HumanMethylation450K BeadChip array
(450K) or the Infinium MethylationEPIC BeadChip (850K) microarray
provide higher resolution for analyzing DNA methylation on a genome-
wide scale (104, 105). Although not offering as much genome cover-
age as whole-genome bisulfite sequencing (WGBS), the Illumina ar-
rays analyze a significant proportion of total sites for DNA methyla-
tion at 853,307 CpG sites (EPIC/850K) and 485,764 CpG sites (450K)
across the human genome. The CpG sites interrogated by the 850K ar-
ray include 439,562 CpGs out of 482,421 CpGs included in the 450K
microarray and an additional 413,745 new CpG sites that were not in-
cluded in the 450K microarray. The EPIC array provides a highly reli-
able genomic platform for studying DNA methylation patterns across
the genome especially in underexplored territories including enhancer
sequences (106). Furthermore, in comparison to WGBS, Illumina mi-
croarrays provide good value for money in terms of desired coverage,
resolution, and number of samples that can be analyzed, providing large
amounts of high-quality data that can be easily input into epigenetic
clock algorithms.
Advantages of using these approaches include the production of
large datasets that can be analyzed by streamlined analytical pipelines,
providing important information on the epigenome-wide landscape.
Several sophisticated computational tools and software are available
for the analysis and interpretation of large EWAS datasets. The rel-
evant concepts, computational methods, and software for the analy-
sis and interpretation of large DNA methylation data as well as sta-
tistical considerations have been thoroughly reviewed by Bock and
colleagues (107, 108). These statistical approaches allow for compu-
tation of epigenetic age, and are able to control for false discovery
rates and adjust for cell and tissue variation, which are all major
sources of confounding in DNA methylation studies. Some of the pop-
ular and widely used software for processing and analysis of bisul-
fite microarray data in particular include minfi (109), RnBeads (110),
The Chip Analysis Methylation Pipeline (ChAMP) (111), and methy-
lumi (112). Furthermore, other software packages such as dmrFinder
(113), DMRcate (14), and IMA (114) are available for the identifica-
tion of differentially methylated regions (DMRs). New platforms such
as CandiMeth (https://github.com/sjthursby/CandiMeth) are also mak-
ing it easier for those with little bioinformatics experience to look
at methylation across the genome in samples for which array data is
available.
Conclusion
Nutritional epigenomics has highlighted diet as a critical factor with the
potential to influence both healthspan and lifespan. Novel insights into
how perturbations in 1-carbon metabolism influence DNA methylation
and data from epigenome-wide studies of nutrition interventions offer
promising insights to understanding how diet impacts the methylome
during healthy aging and disease. Epigenetic clocks provide an exciting
additional insight into how preventive and treatment strategies may in-
crease the healthspan of an aging global population. Despite the height-
ened research interests in nutritional epigenomics, the field is still beset
with several methodological challenges, which greatly impact the qual-
ity of evidence currently available. The population under study must be
extensively characterized to identify and exclude possible confounding
factors. Robust study designs, which utilize randomization and mea-
sure appropriate biomarkers, are required to clarify the factors under-
lying epigenetic aging. Replication and validation of findings in multi-
ple independent cohorts are essential to reduce reporting of false posi-
tive findings. Epigenetic clocks described here have sampled individuals
from a wide spectrum of ages. A DNA methylation clock which focuses
on older people or those with specific diseases could help to more ac-
curately predict age-related disease and help to identify factors which
delay or prevent this progression. Improvements in estimating time to
disease have been made in the latest GrimAge clock, which is signifi-
cantly more predictive than chronological age in estimating time to var-
ious diseases; however, much additional research is required to advance
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our knowledge and understanding in relation to coronary heart disease.
Longitudinal studies offer the important advantage of tracking individ-
uals over extended periods to enable the identification of factors which
influence the diagnosis and treatment of disease, making these studies
particularly valuable for clarifying whether observed changes in DNA
methylation are a result of disease or have a causal role. A better under-
standing of the DNA methylome during aging will offer the opportunity
to promote healthy aging and identify nutritional interventions which
delay or prevent age-related disease in order to influence public health
outcomes and policies.
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